文献速递胸部技术与安全PETCT

PET/CT深度学习模型估算肺结节恶性概率并与Herder模型对照

Deep learning-based malignancy probability estimation of pulmonary nodules in PET/CT imaging.
PubMed 文献 · Eur Radiol · 2026-07-11

单中心回顾性研究纳入436例患者的533个不确定肺结节,以病理或至少2年良性随访为参考标准,开发仅使用PET/CT影像数据的深度学习模型AITO-PETCT-MP。在161个结节的测试集上,该模型AUC为0.78,非劣于Herder模型的0.73,且落在7名临床医师表现范围内。

要点

  • AITO-PETCT-MP仅用影像数据即可估算肺结节恶性概率,AUC非劣于Herder模型。
  • BTS随访分层中Herder模型将更多良性结节直接治疗,临床使用需警惕过度处理。
  • 深度学习模型与临床医师均较Herder模型将更多恶性结节分入CT随访。

核心结论

  • AITO-PETCT-MP在仅使用影像数据条件下对肺结节恶性概率估算非劣于指南推荐的Herder模型。
  • 该模型诊断效能位于7名临床医师表现范围之内。
  • Herder模型与临床医师在BTS随访分层上的差异提示其与当前临床实践存在患者管理差异。

研究设计与样本

  • 单中心回顾性研究,纳入436例患者的533个不确定肺结节,其中268个为恶性。
  • 结节平均直径18.4 mm(SD ± 12.1),以组织病理证实或国家癌症登记处至少2年良性随访为参考标准。
  • 在包含161个结节(80个恶性)的测试集上与Herder模型及7名临床医师进行阅片对照研究。

诊断标准与关键数值

  • AITO-PETCT-MP AUC为0.78(95% CI:0.70-0.85),Herder模型AUC为0.73(95% CI:0.65-0.80),非劣效性p=0.005。
  • 经验丰富临床医师平均AUC为0.80(95% CI:0.75-0.85),7名医师AUC范围为0.74-0.87。
  • BTS随访分层中Herder模型将更多良性结节分入潜在直接治疗(26/81),AITO-PETCT-MP与临床医师均为3/81。

临床应用与阅片要点

  • 在日常阅片中可参考AITO-PETCT-MP对不确定肺结节的恶性概率估算作为Herder模型的替代或补充。
  • 基于Herder模型的BTS分层可能使部分良性结节被直接治疗,报告时应结合临床与影像综合判断。
  • AITO-PETCT-MP与临床医师将更多恶性病例分入CT随访而减少直接治疗,可能更贴近当前实际管理路径。

局限性

  • 本研究为单中心回顾性设计,模型的泛化性能有待外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The current BTS guidelines recommend evaluation of suspicious pulmonary nodules using [18F]FDG-PET/CT imaging, followed by Herder model risk stratification. However, it is based on limited imaging features, which may limit diagnostic accuracy. This study aims to develop a PET/CT-based deep learning (DL) model for malignancy probability estimation (AITO-PETCT-MP) and compare its performance to the Herder model and clinician performance.

MATERIALS AND METHODS: In a single-center retrospective study, we collected 533 indeterminate pulmonary nodules (268 malignant) with a mean diameter of 18.4 mm (SD ± 12.1) in 436 patients. Histopathological malignancy confirmation or a minimum 2-year benign national cancer registry follow-up served as the reference standard. Model diagnostic performance was compared against the Herder model and seven clinicians in a reader study on a test set of 161 nodules (80 malignant).

RESULTS: AITO-PETCT-MP achieved an AUC of 0.78 [95% CI: 0.70-0.85] compared to the Herder model: AUC = 0.73 [0.65-0.80] (non-inferiority: p = 0.005). On average, experienced clinicians achieved an AUC of 0.80 [0.75-0.85]. Stratifying into BTS follow-up categories, the Herder model referred more benign nodules for potential direct treatment (26/81) than AITO-PETCT-MP and clinicians (both 3/81), while AITO-PETCT-MP and clinicians assigned more malignant cases to CT surveillance instead of direct treatment.

CONCLUSION: AITO-PETCT-MP demonstrated non-inferior performance to the guideline-recommended Herder model, while only using imaging data. Diagnostic performance fell in the performance range of seven clinicians. Differences in BTS follow-up recommendations between the Herder model and clinicians suggest a difference in patient management compared to current clinical practice.

KEY POINTS: Question How well can an imaging-only deep learning model estimate pulmonary nodule malignancy probability on [18F]FDG-PET/CT compared to the established Herder model and expert clinicians? Findings The model (AITO-PETCT-MP) performed non-inferior to the Herder model (AUC 0.78 vs 0.73, p = 0.005) and comparably to seven expert readers (AUC 0.74-0.87). Clinical relevance BTS-based follow-up stratification showed the Herder model referred more benign nodules to potential direct treatment than clinicians and AITO-PETCT-MP, while assigning fewer malignant cases to surveillance. This suggests a difference between Herder recommendations and current clinical practice.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Leijten, Aarntzen, Verhoeven, et al. Deep learning-based malignancy probability estimation of pulmonary nodules in PET/CT imaging. Eur Radiol. 2026. PMID: 42432262. doi:10.1007/s00330-026-12744-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。